Quantifying the financial burden of households’ out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994–2014 S Selvaraj, HH Farooqui, A Karan BMJ open 8 (5), e018020, 2018 | 180 | 2018 |
High level expert group report on universal health coverage for India Planning Commission eSocialSciences Working Papers, 2011 | 109 | 2011 |
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: evidence from pharmaceutical sales data HH Farooqui, S Selvaraj, A Mehta, DL Heymann PloS one 13 (10), e0204805, 2018 | 97 | 2018 |
Optimal governance and implementation of vaccination programmes to contain the COVID-19 pandemic M Piraveenan, S Sawleshwarkar, M Walsh, I Zablotska, S Bhattacharyya, ... Royal Society open science 8 (6), 210429, 2021 | 93 | 2021 |
Burden of severe pneumonia, pneumococcal pneumonia and pneumonia deaths in Indian states: modelling based estimates H Farooqui, M Jit, DL Heymann, S Zodpey PloS one 10 (6), e0129191, 2015 | 93 | 2015 |
Universal health coverage in India: Progress achieved & the way forward S Zodpey, HH Farooqui Indian Journal of Medical Research 147 (4), 327-329, 2018 | 70 | 2018 |
Outpatient antibiotic prescription rate and pattern in the private sector in India: evidence from medical audit data HH Farooqui, A Mehta, S Selvaraj PloS one 14 (11), e0224848, 2019 | 56 | 2019 |
Pharmaceutical pricing policy: a critique S Selvaraj, H Hasan, M Chokshi, A Sengupta, A Guha, M Shiva, ... Economic and Political Weekly, 20-23, 2012 | 33 | 2012 |
A critical analysis of concentration and competition in the Indian pharmaceutical market A Mehta, H Hasan Farooqui, S Selvaraj PloS one 11 (2), e0148951, 2016 | 29 | 2016 |
A cross-sectional survey of the models in Bihar and Tamil Nadu, India for pooled procurement of medicines M Chokshi, HH Farooqui, S Selvaraj, P Kumar WHO South-East Asia journal of public health 4 (1), 78-85, 2015 | 28 | 2015 |
Did the poor gain from India’s health policy interventions? Evidence from benefit-incidence analysis, 2004–2018 S Selvaraj, AK Karan, W Mao, H Hasan, I Bharali, P Kumar, O Ogbuoji, ... International journal for equity in health 20, 1-15, 2021 | 17 | 2021 |
Clinical profile and opportunistic infection in HIV/AIDS patients attending SS Hospital, Varanasi S Pandey, S Sundar, H Hasan, R Shankar, RP Singh Indian J Prev Soc Med 39 (1), I2, 2008 | 17 | 2008 |
What is the Impact of Covid-19 Pandemic on the RCH (Reproductive and Child Health) Programme in Rajasthan, because of nationwide lockdown (April 2020 to June 2020)? DP Kumar, H Hasan Farooqui Available at SSRN 3913556, 2021 | 16* | 2021 |
Correlation of CD4+ T cell count with serum zinc, copper, and selenium in HIV positive individuals A Malviya, H Hasan, A Hussain The Internet Journal of Epidemiology 6 (2), 2008 | 16 | 2008 |
The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008–18 HH Farooqui, S Selvaraj, A Mehta, MR Mathur JAC-antimicrobial resistance 2 (3), dlaa076, 2020 | 15 | 2020 |
Multinational enterprises and sustainable development PN Ghauri, X Fu, J Väätänen Emerald Group Publishing, 2017 | 15 | 2017 |
Draft drug price policy 2011: legitimising unaffordable medicine prices? S Selvaraj, HH Farooqui Economic and Political Weekly, 13-17, 2012 | 14 | 2012 |
Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis S Selvaraj, HH Farooqui, A Mehta BMJ open 9 (1), e024200, 2019 | 13 | 2019 |
Diabetologist's perspective on practice of evidence based diabetes management in India H Hasan, S Zodpey, A Saraf Diabetes Research and Clinical Practice 95 (2), 189-193, 2012 | 13 | 2012 |
Improving governance and accountability in India’s Medicine supply system S Selvaraj, M Chokshi, H Hasan, P Kumar Draft Report Submitted to Results for Development Institute. New Delhi …, 2010 | 13 | 2010 |